Page last updated: 2024-11-04

vorinostat and Allergic Encephalomyelitis

vorinostat has been researched along with Allergic Encephalomyelitis in 2 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thewissen, K1
Broux, B1
Hendriks, JJ1
Vanhees, M1
Stinissen, P1
Slaets, H1
Hellings, N1
Ge, Z1
Da, Y1
Xue, Z1
Zhang, K1
Zhuang, H1
Peng, M1
Li, Y1
Li, W1
Simard, A1
Hao, J1
Yao, Z1
Zhang, R1

Other Studies

2 other studies available for vorinostat and Allergic Encephalomyelitis

ArticleYear
Tolerogenic Dendritic Cells Generated by In Vitro Treatment With SAHA Are Not Stable In Vivo.
    Cell transplantation, 2016, Volume: 25, Issue:6

    Topics: Animals; Apoptosis; Bone Marrow Cells; CD11c Antigen; Cell Movement; Cells, Cultured; Cytokines; Den

2016
Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis.
    Experimental neurology, 2013, Volume: 241

    Topics: Animals; Antigens, CD; Cell Count; Cell Differentiation; Cell Polarity; Cell Proliferation; Cells, C

2013